Skip to content

Clinical trials

Dermatomyositis trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dermatomyositis Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20171
20211
20221
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting3
Completed2
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chugai Pharmaceutical2
Alexion Pharmaceuticals, Inc.1
AstraZeneca1
Bristol-Myers Squibb1
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company1
Novartis Pharmaceuticals1
argenx1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dermatomyositis8
Polymyositis4
Myositis3
Antiphospholipid Syndrome2
Behcet Syndrome2
Pemphigoid, Bullous2
Purpura, Thrombocytopenic, Idiopathic2
Arthritis, Rheumatoid1
Autoimmune Diseases1
Connective Tissue Diseases1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.